Wendy Rubinstein

Wendy Rubinstein, MD, PhD, FACP, FACMG is Director of Personalized Medicine at FDA in the Center for Devices and Radiological Health. Dr. Rubinstein is a board-certified clinical geneticist and clinical molecular geneticist who directed academic cancer genetics programs for 15 years at three NCI-designated Comprehensive Cancer Centers. From 211 to 217 she was a Senior Scientist at the National Institutes of Health where she launched and directed the NIH Genetic Testing Registry (GTR) and ultimately served as Chief of Medical Genetics and Human Variation at the National Center for Biotechnology Information, hosting flagship information resources including ClinVar, dbSNP, dbGaP, GeneReviews, and GTR. Subsequently, Dr. Rubinstein was Deputy Medical Director of CancerLinQ, the American Society of Clinical Oncology’s real world data platform aimed at improving the quality of care for patients with cancer. An NIH Medical Scientist Training Program scholarship awardee, Dr. Rubinstein earned her MD and PhD degrees at the Mount Sinai School of Medicine. She has authored publications on gene discovery (SDHD), variant interpretation, pharmacogenomics, genetic risk modifiers, clinical practice guidelines, and health information technology.